THEIn diagnosis of front -time dementia received by Bruce Willis in 2022 he lit attention on one of the most early and devastating dementia forms of dementia. The actor, today 69 -year -oldwould gradually lose the ability to talk, read and walk. If the family speaks of stable conditions, several international media report a significant worsening. The case of Bruce Willis gave visibility to an often underestimated diseasepushing the debate on new therapeutic horizons and on the needs of those who assist FTD patients every day.
Bruce Willis lights the headlights on dementia
The case of Bruce Willis has contributed decisively to bringing front -time dementia to the attention of public opinion. Today research works on several fronts to find effective solutions, while in Italy one grows Support network dedicated to patients and caregivers. Understand theemotional impact of the disease And guarantee access to care and services The key remains to face one of the most complex challenges in the field of neuroscience. The family decision to publicly share diagnosis has made it possible to raise public awareness, also pushing the world of research to accelerate efforts. There is still no curebut the combination of New clinical experiments It is greater attention to the psychological well -being of those who assist could represent an important change of step in the management of this disease.
What is frontotemporal dementia
There Frontotemporal dementia (FTD) It is a form of early dementia that mainly affects i Frontal lobes and brain storms, areas responsible for controlling behavior, language and personality. Unlike Alzheimer’s, it often begins in subjects between 45 and 65 years And it can initially manifest itself with changes in personality, uninhibion, apathy or difficulty in language. There are different clinical variants of the FTD: the behavioral one (the most common), primary progressive aphasia and semantic dementia. In about 40% of cases it is hereditary and can be linked to genetic mutations such as those of the GRN, MAPT and C9orf72 genes. There is no definitive cure, But the symptomatic therapies they multidisciplinary interventions can improve the quality of life of the patient and his family.
The emotional load of the caregiver
As in the case of Bruce Willis, the path of frontotemporal dementia deeply involves not only the patient but also those who take care of it. Caregiver often face one Intense emotional stress, with symptoms of burnout, anxiety and depression. The behavioral changes of the sick person, such as apathy or disinhibition, can seriously compromise daily life and emotional relationships. The social stigma which still surrounds this pathology contributes to a sense of isolation and frustration, while the phase prior to the diagnosis is often characterized by confusion and effort in obtaining clear responses. Some non -pharmacological interventions, such as the music therapy, multisensory environments and the simulated presentation therapyare revealing useful in providing emotional relief both for patients and their family members.
New therapies in the experimental phase
The international scientific community is working on Innovative approaches which could, in the future, change the course of front -time dementia.
AL001 (Latzinemab): Monoclonal antibody in phase II, also tested in Italy atBesta Institute of Milanto combat mutations in the GRN and C9orf72 genes.
AVB-101: Gene therapy currently in phase 1/2, experienced in the USA, the United Kingdom and other European countries.
Sodium selenato: Used in an Australian trial, he showed promising results in reducing the Tau protein.
IL-2/CTLA4-IG combination: An American study highlighted its effectiveness in cognitive slowdown without significant side effects.
Alternative approaches: include pills that can increase progranulin, Cell therapies with NK cells and use of Osdocin to counter apathy.
Bruce Willis (Epa/Will Oliver)
Specialized Italian structures and associations
In Italy a network of structures specialized in the diagnosis and management of front -time dementia is active. Among these, IRCCS Carlo Besta Neurological Institute of Milan, theIRCCS San Raffaele, Milan, IRCCS Humanitas Clinical Institute, Rozzano (MI), Auxological San Luca and Moses Bianchi, Milan/Monza e Policlinico Umberto I of Rome.
Alongside the clinical centers, realities such as AIMFT (Italian Association of Frontotemporal disease), Founded in Brescia in 2010, which promotes assistance, information events and early diagnosis orientation, founded in Brescia in 2010, which promotes awareness, assistance and support activities for families.
I woman © RESERVED REPRODUCTION